News

Stock Movers: Circle Falls, Disney Climbs, Moderna Meets Flu Shot Goal
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Fierce Biotech17h
Moderna's mRNA flu vaccine beats approved competitor in latest phase 3 win, teeing up push to FDA
The latest phase 3 win is a boost for Moderna’s attempts to create a flu/COVID combination vaccine. The company withdrew a filing for FDA approval for its combo candidate last month while it waited ...
MarketWatch17h
Moderna Sees Positive Phase 3 Results for Seasonal Flu Vaccine
Moderna's messenger RNA flu vaccine candidate has shown has shown positive results in a late-stage trial. The biotechnology company said Monday its seasonal influenza vaccine candidate, mRNA-1010, ...
BioSpace1d
Moderna, Merck, UroGen, Score RSV and Cancer Nods in June
The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...
Investor's Business Daily on MSN14h
Did Down-And-Out Moderna Just Unlock The Key To Its Future Profitability?
Moderna stock veered higher Monday after its flu shot proved to be as effective as older technology in a final-phase study.
What is myocarditis? What to know about heart risk warning related to COVID-19 vaccines
The FDA has updated labels on the top two COVID-19 vaccines to warn of a rare heart side effect, mostly seen in young men.
StockStory.org on MSN4d
The Top 5 Analyst Questions From Moderna’s Q1 Earnings Call
Moderna’s first quarter results were met with a negative market reaction, as revenue fell short of Wall Street expectations ...
BioSpace3d
ACIP Skips Votes on COVID and Moderna’s mRESVIA but Scrutinzes mRNA Vaccine Safety
The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...